NDC 42385-928 – Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate
Efavirenz 600 mg/1; Lamivudine 300 mg/1; Tenofovir Disoproxil Fumarate 300 mg/1 · Tablet, Film Coated · Oral
Product NDC42385-928
Product details
- Brand name
- Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate
- Generic name
- Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate
- Labeler
- Laurus Labs Limited
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- ANDA · ANDA212786
- Marketed since
- May 14, 2020
- Listing expires
- December 31, 2026
- Pharmacologic class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Active ingredients
- Efavirenz 600 mg/1
- Lamivudine 300 mg/1
- Tenofovir Disoproxil Fumarate 300 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 42385-928-30 | 30 TABLET, FILM COATED in 1 BOTTLE (42385-928-30) | May 14, 2020 |
| 42385-928-90 | 90 TABLET, FILM COATED in 1 BOTTLE (42385-928-90) | May 14, 2020 |
Other Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate products
- 42385-929 Efavirenz 400 mg/1; Lamivudine 300 mg/1; Tenofovir Disoproxil… · Tablet, Film Coated · Laurus Labs Limited